Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism


Author index

Page Path
Bart L. Clarke 1 Article
Bone Metabolism
Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach
Guido Zavatta, Bart L. Clarke
Endocrinol Metab. 2021;36(3):525-535.   Published online June 1, 2021
  • 7,186 View
  • 419 Download
  • 13 Web of Science
  • 13 Crossref
AbstractAbstract PDFPubReader   ePub   
Since normocalcemic primary hyperparathyroidism (NHPT) was first defined at the Third International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism in 2008, many papers have been published describing its prevalence and possible complications. Guidelines for the management of this condition are still lacking, and making the diagnosis requires fulfillment of strict criteria. Recent studies have shown that intermittent oscillations of serum calcium just below and slightly above the normal limits are very frequent, therefore challenging the assumption that serum calcium must be consistently normal to make the diagnosis. There is debate if these variations in serum calcium outside the normal range should be included under the rubric of NHPT or, rather, a milder form of classical primary hyperparathyroidism. Innovative approaches to define NHPT have been proposed that still need to be validated in prospective studies. Non-classical complications, especially cardiovascular complications, have been associated with NHPT, indicating that hyperparathyroidism may be a cardiovascular risk factor. New associations between parathyroid hormone (PTH) and several other comorbidities have also been reported from observational studies, suggesting that excessive PTH secretion might cause tissue dysfunction independent of serum calcium. Heterogeneous studies using different definitions of NHPT, however, make it difficult to draw definitive conclusions regarding the role of PTH excess when complications other than osteoporosis or kidney stones are described. This review will focus on clinical aspects and suggest an approach to NHPT.


Citations to this article as recorded by  
  • Surgery for Normocalcemic Hyperparathyroidism
    Pallavi Kulkarni, David Goldenberg
    Otolaryngologic Clinics of North America.2024; 57(1): 111.     CrossRef
  • Linea guida sulla gestione terapeutica dell’iperparatiroidismo primario sporadico nell’adulto
    Fabio Vescini, Marco Boniardi, Marina Carotti, Elena Castellano, Cristiana Cipriani, Cristina Eller-Vainicher, Sandro Giannini, Maurizio Iacobone, Francesca Pace, Antonio Stefano Salcuni, Federica Saponaro, Stefano Spiezia, Annibale Versari, Guido Zavatta
    L'Endocrinologo.2024; 25(2): 222.     CrossRef
  • Evaluation of the Thiazide Challenge Test to Differentiate Primary From Hypercalciuria-Related Hyperparathyroidism
    Ewout Verly, Bruno Lapauw, Charlotte Verroken
    The Journal of Clinical Endocrinology & Metabolism.2024;[Epub]     CrossRef
  • Secular trends in the incidence and treatment patterns of primary hyperparathyroidism in Korea: a nationwide cohort study
    Kyoung Jin Kim, Seungjin Baek, Min Heui Yu, Sungjae Shin, Sungjoon Cho, Yumie Rhee, Namki Hong
    JBMR Plus.2024;[Epub]     CrossRef
  • DXA-based bone strain index in normocalcemic primary hyperparathyroidism
    Gaia Tabacco, Anda Mihaela Naciu, Carmelo Messina, Gianfranco Sanson, Luca Rinaudo, Roberto Cesareo, Stefania Falcone, Nicola Napoli, Fabio Massimo Ulivieri, Andrea Palermo
    Osteoporosis International.2023; 34(5): 999.     CrossRef
  • Iperparatiroidismo primario normocalcemico
    Silvia Egiddi, Luigi Bonifazi Meffe, Anda Mihaela Naciu, Gaia Tabacco, Nicola Napoli, Andrea Palermo
    L'Endocrinologo.2023; 24(3): 249.     CrossRef
  • The Russian registry of primary hyperparathyroidism, latest update
    Natalia G. Mokrysheva, Anna K. Eremkina, Alina R. Elfimova, Elena V. Kovaleva, Anastasiia P. Miliutina, Ekaterina E. Bibik, Anna M. Gorbacheva, Ekaterina A. Dobreva, Irina S. Maganeva, Julia A. Krupinova, Rustam H. Salimkhanov, Lizaveta A. Aboishava, Elen
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Incidental Normocalcemic Primary Hyperparathyroidism Presenting With Symptomatic Hypophosphatemia: A Case Report
    Omar Tabbikha, Joanne Chamy, Michael El Khoury
    Cureus.2023;[Epub]     CrossRef
  • Long-term effects of hypercalcemia in kidney transplant recipients with persistent hyperparathyroidism
    Juan Carlos Ramirez-Sandoval, Lluvia Marino, Gabriel Cojuc-Konigsberg, Estefania Reul-Linares, Nathalie Desire Pichardo-Cabrera, Cristino Cruz, Elisa Naomi Hernández-Paredes, Nathan Berman-Parks, Vanessa Vidal-Ruíz, Jonathan Mauricio Estrada-Linares, Alfr
    Journal of Nephrology.2023;[Epub]     CrossRef
  • Evaluating Patients for Secondary Causes of Osteoporosis
    E. Michael Lewiecki
    Current Osteoporosis Reports.2022; 20(1): 1.     CrossRef
  • Preoperative Thoracic Muscle Mass Predicts Bone Density Change After Parathyroidectomy in Primary Hyperparathyroidism
    Seung Won Burm, Namki Hong, Seunghyun Lee, Gi Jeong Kim, Sang Hyun Hwang, Jongju Jeong, Yumie Rhee
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(6): e2474.     CrossRef
  • Applications of Metabolomics in Calcium Metabolism Disorders in Humans
    Beata Podgórska, Marta Wielogórska-Partyka, Joanna Godzień, Julia Siemińska, Michał Ciborowski, Małgorzata Szelachowska, Adam Krętowski, Katarzyna Siewko
    International Journal of Molecular Sciences.2022; 23(18): 10407.     CrossRef
  • Serum Calcium/Phosphorus Ratio in Biochemical Screening of Primary Hyperparathyroidism
    Nagihan Bestepe, Fatma Neslihan Cuhaci, Burcak Polat, Berna Evranos Ogmen, Didem Ozdemir, Reyhan Ersoy, Bekir Cakir
    Revista da Associação Médica Brasileira.2022; 68(12): 1668.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism